
Epsilogen Acquires TigaTx to Lead Pan-Isotype Cancer Antibodies
The acquisition combines IgA antibody assets and expertise of Boston-based TigaTx with Epsilogen’s assets and expertise in IgE to create the world’s leading pan-isotype cancer
The acquisition combines IgA antibody assets and expertise of Boston-based TigaTx with Epsilogen’s assets and expertise in IgE to create the world’s leading pan-isotype cancer
Juniper Communities, a leading owner/operator of senior living communities, has entered into a strategic partnership with National Health Investors, Inc., a premier real estate investment
iOncologi, Inc., a clinical-stage biopharmaceutical company focused on advancing immunotherapy platform technologies, announced the acquisition of TargImmune Therapeutics, a biotechnology company specializing in novel tumor
Fuel up with free Health Tech Insights